Plain Language Summaries is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • How to
  • FAQs
  • Publications
  • Advisory Panel
    • Plain Language Advisors
    • Scientific Content Advisors
  • Supporters
  • Blog
  • About us
  • Contact Us

children

25th Feb 2026

Plain language summary of clinical research examining burosumab safety in young patients with X-linked hypophosphatemia

28th Oct 2025

Vagus nerve stimulation therapy for severe childhood epilepsy over 2 years: plain language summary

The PLSP summarizes results from the phase 2/3 KidCOVE trial examining mRNA-1273 (Moderna’s COVID-19 vaccine) in children 6 through 11 years of age.
28th Jul 2023

Plain Language Summary: evaluating Moderna’s COVID-19 vaccine in children ages 6 to 11

26th Nov 2021

Vosoritide treatment accelerates bone growth in children with achondroplasia (Animated video)

Copyright © 2026 · Plain Language Summaries · Terms and conditions · Privacy policy · Cookie policy